These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 12653169)
21. Effect of leukotriene receptor antagonist therapy on the risk of asthma exacerbations in patients with mild to moderate asthma: an integrated analysis of zafirlukast trials. Barnes NC; Miller CJ Thorax; 2000 Jun; 55(6):478-83. PubMed ID: 10817796 [TBL] [Abstract][Full Text] [Related]
22. Randomized placebo-controlled study comparing a leukotriene receptor antagonist and a nasal glucocorticoid in seasonal allergic rhinitis. Pullerits T; Praks L; Skoogh BE; Ani R; Lötvall J Am J Respir Crit Care Med; 1999 Jun; 159(6):1814-8. PubMed ID: 10351924 [TBL] [Abstract][Full Text] [Related]
23. The effect of zafirlukast on repetitive exercise-induced bronchoconstriction: the possible role of leukotrienes in exercise-induced refractoriness. Dessanges JF; Préfaut C; Taytard A; Matran R; Naya I; Compagnon A; Dinh-Xuan AT J Allergy Clin Immunol; 1999 Dec; 104(6):1155-61. PubMed ID: 10588995 [TBL] [Abstract][Full Text] [Related]
24. The leukotriene receptor antagonist montelukast in the treatment of chronic idiopathic urticaria: a single-blind, placebo-controlled, crossover clinical study. Erbagci Z J Allergy Clin Immunol; 2002 Sep; 110(3):484-8. PubMed ID: 12209099 [TBL] [Abstract][Full Text] [Related]
25. Antitussive effect of the leukotriene receptor antagonist zafirlukast in subjects with cough-variant asthma. Dicpinigaitis PV; Dobkin JB; Reichel J J Asthma; 2002 Jun; 39(4):291-7. PubMed ID: 12095178 [TBL] [Abstract][Full Text] [Related]
26. Therapeutic effect of zafirlukast as monotherapy in steroid-naive patients with severe persistent asthma. Kemp JP; Minkwitz MC; Bonuccelli CM; Warren MS Chest; 1999 Feb; 115(2):336-42. PubMed ID: 10027429 [TBL] [Abstract][Full Text] [Related]
27. A randomized placebo-controlled double-blind pilot study of methotrexate in the treatment of H1 antihistamine-resistant chronic spontaneous urticaria. Sharma VK; Singh S; Ramam M; Kumawat M; Kumar R Indian J Dermatol Venereol Leprol; 2014; 80(2):122-8. PubMed ID: 24685847 [TBL] [Abstract][Full Text] [Related]
29. Acrivastine versus hydroxyzine in the treatment of cholinergic urticaria. A placebo-controlled study. Kobza Black A; Aboobaker J; Gibson JR; Harvey SG; Marks P Acta Derm Venereol; 1988; 68(6):541-4. PubMed ID: 2467496 [TBL] [Abstract][Full Text] [Related]
30. A comparison of acrivastine versus chlorpheniramine in the treatment of chronic idiopathic urticaria. Gale AE; Harvey SG; Calthrop JG; Gibson JR J Int Med Res; 1989; 17 Suppl 2():25B-27B. PubMed ID: 2569998 [TBL] [Abstract][Full Text] [Related]
31. Acrivastine. A review of its pharmacological properties and therapeutic efficacy in allergic rhinitis, urticaria and related disorders. Brogden RN; McTavish D Drugs; 1991 Jun; 41(6):927-40. PubMed ID: 1715267 [TBL] [Abstract][Full Text] [Related]
32. Acrivastine--an evaluation of initial and peak activity in human skin. Marks P; Manna VK; Gibson JR J Int Med Res; 1989; 17 Suppl 2():3B-8B. PubMed ID: 2569999 [TBL] [Abstract][Full Text] [Related]
33. Summary of clinical trials with zafirlukast. Calhoun WJ Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 2):S238-45; discussion S245-8. PubMed ID: 9647606 [TBL] [Abstract][Full Text] [Related]
34. Leukotriene E(4)-induced persistent eosinophilia and airway obstruction are reversed by zafirlukast in patients with asthma. Laitinen A; Lindqvist A; Halme M; Altraja A; Laitinen LA J Allergy Clin Immunol; 2005 Feb; 115(2):259-65. PubMed ID: 15696079 [TBL] [Abstract][Full Text] [Related]
35. Effects of the cysteinyl leukotriene receptor antagonists pranlukast and zafirlukast on tracheal mucus secretion in ovalbumin-sensitized guinea-pigs in vitro. Liu YC; Khawaja AM; Rogers DF Br J Pharmacol; 1998 Jun; 124(3):563-71. PubMed ID: 9647482 [TBL] [Abstract][Full Text] [Related]
36. Zafirlukast improves pulmonary function in patients with moderate persistent asthma receiving regular inhaled steroids: a prospective randomized control study. Huang CJ; Wang CH; Liu WT; Yang MC; Lin HC; Yu CT; Shiao CJ; Tan CC; Yang CK; Kuo HP Chang Gung Med J; 2003 Aug; 26(8):554-60. PubMed ID: 14609035 [TBL] [Abstract][Full Text] [Related]
37. Desloratadine in combination with montelukast in the treatment of chronic urticaria: a randomized, double-blind, placebo-controlled study. Nettis E; Colanardi MC; Paradiso MT; Ferrannini A Clin Exp Allergy; 2004 Sep; 34(9):1401-7. PubMed ID: 15347373 [TBL] [Abstract][Full Text] [Related]
38. A comparison of acrivastine versus clemastine and placebo in the treatment of patients with chronic idiopathic urticaria. Leyh F; Harvey SG; Gibson JR; Manna VK J Int Med Res; 1989; 17 Suppl 2():22B-24B. PubMed ID: 2569997 [TBL] [Abstract][Full Text] [Related]
39. Leukotriene receptor antagonists as add-on therapy to antihistamines for urticaria: Systematic review and meta-analysis of randomized clinical trials. Rayner DG; Liu M; Chu AWL; Chu X; Guyatt GH; Oykhman P; Cao DJ; Moellman J; Ben-Shoshan M; Baker DR; Waserman S; Lang D; Sheikh J; Mathur SK; Beck LA; Khan DA; Oliver ET; Asiniwasis RN; Cole EF; Wheeler KE; Runyon L; Chan J; Trayes KP; Eftekhari S; Gardner DD; Winders T; Saini SS; Bernstein JA; Chu DK J Allergy Clin Immunol; 2024 Oct; 154(4):996-1007. PubMed ID: 38852861 [TBL] [Abstract][Full Text] [Related]
40. An evaluation of zafirlukast in the treatment of asthma with exploratory subset analyses. Tashkin DP; Nathan RA; Howland WC; Minkwitz MC; Simonson SG; Bonuccelli CM J Allergy Clin Immunol; 1999 Feb; 103(2 Pt 1):246-54. PubMed ID: 9949315 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]